Mallinckrodt Inc. Continues Efforts to Fight Medicine Abuse With The Partnership® at Drugfree.org

ST. LOUIS--(BUSINESS WIRE)--Mallinckrodt (NYSE: MNK) announced today that it will continue its collaboration with The Partnership at Drugfree.org for a second year in support of The Medicine Abuse Project. The campaign brings together families, communities, industry, health care professionals, educators, law enforcement and government officials to help save lives by preventing teen medicine abuse. Mallinckrodt is renewing its support as a Gold Sponsor, extending the Company’s strong commitment to fighting abuse, diversion, and misuse of powerful pain medications.